Brandon Nicolay

Brandon Nicolay has extensive experience in the pharmaceutical and biotech industry, with roles at FogPharma, Cedilla Therapeutics, and Agios Pharmaceuticals. Brandon has held positions ranging from Scientist to Senior Director, focusing on discovery and translational pharmacology. Prior to their industry roles, Brandon worked in research at Harvard Medical School and University of Illinois at Chicago, studying cancer cell metabolism and tumor suppressor pathways.

Brandon Nicolay earned a Bachelor of Arts in Biology from Carleton College in 2005. Brandon then went on to obtain a Doctor of Philosophy in Biochemistry and Molecular Genetics from the University of Illinois Chicago in 2010.